Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Claritev Corporation (CTEV : NYSE)

• Company Description    Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. Number of Employees: 2,700

• Price / Volume Information    Yesterday's Closing Price: $61.48 Daily Weekly Monthly 20 Day Moving Average: 105,648 shares Shares Outstanding: 16.48 (millions) Market Capitalization: $1,012.88 (millions) Beta: 0.45 52 Week High: $74.00 52 Week Low: $4.80 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -9.33% -10.93% 12 Week 52.37% 38.40% Year To Date 315.97% 272.36%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 7900 TYSONS ONE PLACE SUITE 400 - MCLEAN,VA 22102 USA ph: 212-780-2000 fax: - investor@multiplan.com http://www.claritev.com

• General Corporate Information    Officers Travis S. Dalton - Chief Executive Officer and Director Douglas M. Garis - Executive Vice President and Chief Financial Offic Gerald J. Kozel - Senior Vice President and Chief Accounting Officer Allen R. Thorpe - Lead Independent Director Richard A. Clarke - Director Peer Information Claritev Corporation (HLIS) Claritev Corporation (AZTA) Claritev Corporation (APYI) Claritev Corporation (RNVA) Claritev Corporation (HMSY) Claritev Corporation (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 62548M209 SIC: 7389 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/04/25 Share - Related Items Shares Outstanding: 16.48 Most Recent Split Date: 9.00 (0.03:1) Beta: 0.45 Market Capitalization: $1,012.88 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-3.12 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-13.41 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 3.43 Price / Sales: 1.08 EPS Growth vs. Year Ago Period: 126.67% vs. Previous Quarter: 109.33% Sales Growth vs. Year Ago Period: 3.47% vs. Previous Quarter: 4.43% ROE 06/30/25 - -245.89 03/31/25 - -84.47 12/31/24 - -30.40 ROA 06/30/25 - -3.18 03/31/25 - -3.61 12/31/24 - -2.78 Current Ratio 06/30/25 - 0.98 03/31/25 - 1.02 12/31/24 - 0.82 Quick Ratio 06/30/25 - 0.98 03/31/25 - 1.02 12/31/24 - 0.82 Operating Margin 06/30/25 - -17.51 03/31/25 - -20.72 12/31/24 - -16.87 Net Margin 06/30/25 - -70.91 03/31/25 - -126.96 12/31/24 - -176.85 Pre-Tax Margin 06/30/25 - -83.12 03/31/25 - -140.05 12/31/24 - -190.27 Book Value 06/30/25 - -2.42 03/31/25 - 0.90 12/31/24 - 5.19 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 310.26 12/31/24 - 53.67 Debt-to-Capital 06/30/25 - - 03/31/25 - 99.68 12/31/24 - 98.17

Powered by Zacks Investment Research ©